Merck Says Public Info Bars Whistleblower's Kickback Case
Merck & Co. and two other drugmakers urged the Ninth Circuit on Thursday not to revive a whistleblower suit accusing pharmaceutical companies of violating the False Claims Act by paying kickbacks...To view the full article, register now.
Already a subscriber? Click here to view full article